The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024 were officially signed into law on 10 April 2025, marking a significant development in the UK clinical trials framework ...

While the US Food and Drug Administration has been experiencing recent reorganization and cuts in personnel, the United ...

Representatives of industry and regulation will meet in June to discuss paths forward for the UK’s clinical trials sector ...

The UK’s Office of Life Sciences (OLS) has commissioned an independent review of the country’s commercial clinical trials sector, following the publication of an industry report which found a ...

The first-ever analysis of the UK clinical trial landscape by the Medicines and Healthcare products Regulatory Agency (MHRA) and the University of Liverpool reveals the UK is a global leader in ...

The UK experienced a notable increase in advanced therapy clinical trials in 2024, reaching 187 ongoing trials. This marks a 7% rise from the previous year. Particularly, phase I trials saw an ...